| Type 1 Diabetes Mellitus |
1 |
1 |
| Islet Cell Transplantation |
0 |
0.99 |
| Stem Cell Research and Therapy |
0 |
0.98 |
| Transplantation |
0 |
0.96 |
| Cell Transplantation |
0 |
0.97 |
| Biologic Therapy |
0 |
0.73 |
| Blood |
0 |
0.41 |
| Vein |
0 |
0.21 |
| Healthcare and Medical Technology |
0 |
0.18 |
| Biomedical Technology |
0 |
0.1 |
| Cadaver |
0 |
0.1 |
| Clinical Research |
0 |
0.1 |
| Liver |
0 |
0.1 |
| Retinal Diseases |
0 |
0.08 |
| Abdominal Wall |
0 |
0.07 |
| Hemoglobin A1c |
0 |
0.07 |
| Diabetic Retinopathy |
0 |
0.06 |
| Abdomen |
0 |
0.05 |
| Antebrachial Region |
0 |
0.05 |
| Board Certification |
0 |
0.05 |
| California |
0 |
0.05 |
| Child |
0 |
0.05 |
| CRISPR |
0 |
0.05 |
| Dorsum |
0 |
0.05 |
| Endocrine Society |
0 |
0.05 |
| Europe |
0 |
0.05 |
| Graft |
0 |
0.05 |
| Hemoglobin |
0 |
0.05 |
| Hospital |
0 |
0.05 |
| Immunocompromise |
0 |
0.05 |
| Massachusetts |
0 |
0.05 |
| Poverty |
0 |
0.05 |
| Retinopathy |
0 |
0.05 |
| Seizure |
0 |
0.05 |
| Surgery |
0 |
0.05 |
| Young Adult |
0 |
0.05 |
| Genomic Medicine |
0 |
0.04 |
| Social Determinants of Health |
0 |
0.04 |